Accueil / Tag Archives: Washington (page 10)

Tag Archives: Washington

Breast Cancer More Aggressive, Deadlier in African Women Than Caucasian Women

Tuesday, June 20th 2017 at 9:00am UTC New BVGH initiative to foster cancer research, improve access to prioritized medicines in Africa SEATTLE–(BUSINESS WIRE)– The high burden of breast cancer in women of African heritage, an issue long under-recognized by the medical community, governments, and drug companies, will be highlighted at …

Plus »

Adaptive Biotechnologies annonce une collaboration avec Janssen Biotech, Inc. pour utiliser le test clonoSEQ® afin de mesurer la maladie résiduelle minimale … sur les myélomes multiples traités avec du DARZALEX®

Thursday, June 22nd 2017 at 6:00am UTC Cette collaboration de diagnostic vise à soutenir le développement clinique du DARZALEX SEATTLE–(BUSINESS WIRE)– Adaptive Biotechnologies, leader dans le domaine de la combinaison de séquençage nouvelle génération (SNG) et de la bioinformatique experte visant à profiler les récepteurs de cellules T et B …

Plus »

Introducing Docuvera – Transformative Software to Create Life Science Documentation that Dramatically Increases Compliance and Lowers Costs by 50%

Wednesday, June 21st 2017 at 12:00pm UTC SEATTLE–(BUSINESS WIRE)– Author-it Software Corporation (ASC), a world leader in component authoring and content management solutions, announced today the release of DocuveraTM – a SaaS service that promises to transform how life science documentation is created and managed through the lifecycle of drug …

Plus »

Alpine Immune Sciences Announces Presentation of Preclinical Data Showing Potency of Its First-Generation Dual ICOS and CD28 Antagonist vIgDs in an Animal Model

Wednesday, June 14th 2017 at 12:00pm UTC Company Plans to File IND in 2018 for First in Class Molecule SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc. (Alpine), a biotechnology company developing a next-generation immune modulation platform, today announced results from a preclinical study evaluating first-generation variant Ig domains (vIgDs™) from the …

Plus »

Seattle Genetics and Bristol-Myers Squibb Highlight Interim Phase 1/2 Data Evaluating Combination of ADCETRIS® (Brentuximab Vedotin) and Opdivo® (Nivolumab) in Relapsed Hodgkin Lymphoma at the International Conference on Malignant Lymphoma

Thursday, June 15th 2017 at 10:58am UTC -Combination Data Show 85 Percent Objective Response Rate and 63 Percent Complete Response Rate with an Acceptable Safety Profile in these Pre-Transplant Relapsed or Refractory Classical Hodgkin Lymphoma Patients- -Data Support Recently Initiated Pivotal Phase 3 Clinical Trial Evaluating ADCETRIS and Opdivo Combination …

Plus »

Blaze Bioscience Announces Presentation of Tumor Paint BLZ-100 Clinical Data at Pediatric Neuro-Oncology Basic and Translational Research Conference

Thursday, June 15th 2017 at 10:00am UTC Presentation of Phase 1 pediatric brain cancer clinical data for BLZ-100 (tozuleristide) SEATTLE–(BUSINESS WIRE)– Blaze Bioscience, Inc., the Tumor Paint Company®, a biotechnology company dedicated to improving the lives of cancer patients, today announced that clinical data from the company’s Phase 1 study …

Plus »

FDA Grants Breakthrough Therapy Designation to Omeros’ MASP-2 Inhibitor OMS721 for the Treatment of IgA Nephropathy

Tuesday, June 13th 2017 at 3:30pm UTC – Omeros’ Second Phase 3 Clinical Program for OMS721 Slated to Begin this Year – SEATTLE–(BUSINESS WIRE)– Omeros Corporation (NASDAQ: OMER) today announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to OMS721 for the treatment of Immunoglobulin …

Plus »

LabConnect, Inc., Announces $24.5 Million in Series A Funding

Tuesday, June 13th 2017 at 12:00pm UTC Company’s strong growth and technical expertise in managing clinical trials attracts growth equity investment SEATTLE–(BUSINESS WIRE)– LabConnect, a leading provider of highly customized global central laboratory and support services to biopharmaceutical, medical device, and contract research organizations (CROs), announced today a $24.5 million …

Plus »

Juno Therapeutics to Present at the Goldman Sachs 38th Annual Global Healthcare Conference

Tuesday, June 6th 2017 at 8:05pm UTC SEATTLE–(BUSINESS WIRE)– Juno Therapeutics, Inc. (NASDAQ: JUNO) today announced that it will webcast its presentation at the Goldman Sachs 38th Annual Global Healthcare Conference at 10:00 a.m. PT on Tuesday, June 13, 2017. The presentation will feature a business overview and update by …

Plus »

Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma

Wednesday, June 7th 2017 at 12:00pm UTC CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash.–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the randomized Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL) …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.